Trial Profile
A study in healthy adults of a randomised, controlled vaccine intervention study evaluating the safety and immunogenicity of a Hepatitis B vaccine containing Advax adjuvant
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 08 Jun 2016
Price :
$35
*
At a glance
- Drugs Hepatitis B vaccine (Primary)
- Indications Hepatitis B
- Focus Adverse reactions
- Sponsors Vaxine
- 11 May 2009 Status changed from not stated to active, no longer recruiting.
- 11 May 2009 New trial record